Database Comparison of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) and the SRTR U.S. Transplant Registry  † , ‡ by Gillespie, Brenda W. et al.
American Journal of Transplantation 2010; 10: 1630–1642
Wiley Periodicals Inc.
C© 2010 The Authors
Journal compilation C© 2010 The American Society of
Transplantation and the American Society of Transplant Surgeons
doi: 10.1111/j.1600-6143.2010.03039.x
Database Comparison of the Adult-to-Adult Living
Donor Liver Transplantation Cohort Study (A2ALL)
and the SRTR U.S. Transplant Registry†,‡
B. W. Gillespiea,*, R. M. Merionb, E. Ortiz-Riosc,
L. Tongb, A. Shakedd, R. S. Browne, A. O. Ojof,
P. H. Hayashig, C. L. Bergh, M. M. Abecassisi,
A. S. Ashworthj, C. E. Friesek, J. C. Hongl,
J. F. Trotterm, J. E. Everhartn
and the A2ALL Study Group
aDepartment of Biostatistics, bDepartment of Surgery,
University of Michigan, Ann Arbor, MI
cDivision of Transplantation, Health Resources and
Services Administration, US Department of Health and
Human Services, Bethesda, MD
dDepartment of Surgery, University of Pennsylvania,
Philadelphia, PA
eDepartment of Medicine, Columbia University College of
Physicians & Surgeons, New York, NY
fDepartment of Internal Medicine, University of Michigan,
Ann Arbor, MI
gDepartment of Surgery, University of North Carolina,
Chapel Hill, NC
hDepartment of Medicine, University of Virginia Health
System, Charlottesville, VA
iDepartment of Surgery, Northwestern University,
Chicago, IL
jDepartment of Surgery, Medical College of Virginia Hos-
pitals, Virginia Commonwealth University, Richmond, VA
kDepartment of Surgery, University of California, San
Francisco, San Francisco, CA
lDepartment of Surgery, University of California, Los
Angeles, Los Angeles, CA
mDepartment of Surgery, University of Colorado, Aurora,
CO (Current affiliation = Department of Medicine, Baylor
University Medical Center, Dallas, TX)
nDivision of Digestive Diseases and Nutrition, National
Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Bethesda, MD
*Corresponding author: Brenda Gillespie,
bgillesp@umich.edu
†Presented in part at the American Transplant Congress,
Toronto, Canada, June, 2008.
‡This is publication number 13 of the Adult-to-Adult Living
Donor Liver Transplantation Cohort Study.
Data submitted by transplant programs to the Organ
Procurement and Transplantation Network (OPTN) are
used by the Scientific Registry of Transplant Recipients
(SRTR) for policy development, performance evalua-
tion and research. This study compared OPTN/SRTR
data with data extracted from medical records by re-
search coordinators from the nine-center A2ALL study.
A2ALL data were collected independently of OPTN
data submission (48 data elements among 785 liver
transplant candidates/recipients; 12 data elements
among 386 donors). At least 90% agreement occurred
between OPTN/SRTR and A2ALL for 11/29 baseline re-
cipient elements, 4/19 recipient transplant or follow-up
elements and 6/12 donor elements. For the remaining
recipient and donor elements, >10% of values were
missing in OPTN/SRTR but present in A2ALL, confirm-
ing that missing data were largely avoidable. Other
than variables required for allocation, the percentage
missing varied widely by center. These findings sup-
port an expanded focus on data quality control by
OPTN/SRTR for a broader variable set than those used
for allocation. Center-specific monitoring of missing
values could substantially improve the data.
Key words: Data validation, database, live donor trans-
plantation, liver transplantation, quality assessment
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Introduction
All U.S. transplant programs and organ procurement orga-
nizations (OPOs) are required by the Organ Procurement
and Transplantation Network (OPTN) Final Rule (1,2) to sub-
mit data to OPTN on all individuals who register to receive
an organ transplant or who donate an organ for transplanta-
tion. Demographic, socioeconomic and clinical data, includ-
ing vital status and allograft status are collected on a reg-
ular basis for candidate organ recipients and donors. The
data are ultimately reposited with the Scientific Registry
of Transplant Recipients (SRTR), which is the organization
with statutory responsibility for utilization of OPTN data
for development of allocation policy, program performance
evaluation and research.
OPTN/SRTR data have been the basis of more than 1000
peer-reviewed scientific publications, scores of organ al-
location policies, medical practice guidelines and regu-
lar program-specific reporting of waitlist and transplant
outcomes.
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Although submission is federally mandated, the OPTN/
SRTR data have never been systematically validated
against source documents. The overall accuracy and com-
pleteness of the data depend on range and consistency
checks performed at the time of data entry as well as
additional data cleaning performed by the OPTN contractor
prior to transfer of the data to the SRTR. The Adult-to-Adult
Living Donor Liver Transplantation Cohort Study (A2ALL)
was created in 2002 to investigate the benefits and risks
of living donor liver transplantation (LDLT). The A2ALL
clinical sites collected retrospective data on all potential
liver recipients who had a living donor evaluated between
January 1998 and February 2003 at nine participating
centers. A2ALL research coordinators extracted data
from medical records, imaging and laboratory studies.
One of the objectives of A2ALL was to compare the
completeness and reproducibility of transplant candidate
and donor data elements in OPTN/SRTR with A2ALL.
Methods
Of 819 liver transplant candidates, 34 were excluded: 6 because OPTN
listing date was missing in A2ALL, and 28 because no OPTN liver transplant
listing was found within 30 days of the date reported in A2ALL. Of 605
A2ALL transplant recipients, 11 were excluded due to no OPTN transplant
date within 30 days of the date reported in A2ALL. Of 387 living donors in
A2ALL, one was excluded due to no OPTN donation date within two days
of the date reported in A2ALL. These cases represent data discrepancies
in themselves but are not considered further due to lack of information.
OPTN data were collected for candidate organ recipients from the time of
listing until waitlist removal, transplant failure, or death. Organ donors were
followed for 2 years from the time of donation. The OPTN data, collected
through a web-based data entry system (UNET) since October 1999, were
subject to automated range and consistency checks at the time of data
entry, as well as further queries based on analytic checks. Site audits were
performed to verify data used for organ allocation. Over the years, data
elements have been added or dropped. For example, following the 2002
introduction of the Model for End-stage Liver Disease (MELD) (3), the three
elements needed for MELD score calculation were required. The SRTR
also incorporated extra ascertainment of mortality from the Social Security
Death Master File (SSDMF).
In the A2ALL study, each center employed at least one full-time coordi-
nator who was centrally trained for medical chart review. The coordinator
collected data—without referring to the OPTN data—using a secure web-
based data entry system (BioDBx). The study protocol was approved by
the Institutional Review Board and Privacy Board of each participating cen-
ter and the A2ALL Data Coordinating Center (DCC) prior to beginning data
entry. Subject name, gender and date of birth were submitted to the DCC
for linkage to corresponding OPTN/SRTR data under an approved data use
agreement with the SRTR. As each A2ALL data entry screen was com-
pleted, discrepancies with the linked OPTN/SRTR data were flagged and
required confirmation or modification of the data entered by the A2ALL
coordinator. Subsequent data cleaning, including range and consistency
checks, allowed further opportunities for data correction over 5 years of
analysis. Additional queries were made as additional discrepancies were
found between A2ALL and OPTN/SRTR data during analysis. Thus, a crit-
ical aspect of the design of this study was the attempted resolution of
discrepancies in the two data sets. There was no transfer of corrections
from A2ALL to OPTN or SRTR. For this report, A2ALL data were compared
with OPTN/SRTR data as of February 2009, which may have incorporated
corrections since the original OPTN/SRTR data presented to coordinators in
2003. The OPTN/SRTR form and variable names for all examined variables
are available as supplementary materials.
Comparisons between OPTN/SRTR and A2ALL were made on variables col-
lected in comparable formats in the two databases: 29 baseline elements
for potential recipients, 19 transplant-related elements for liver transplant
recipients and 12 living liver donor-related elements. For each data element,
we present the numbers and percents of values missing in both databases,
missing in OPTN/SRTR but present in A2ALL, present in OPTN/SRTR but
missing in A2ALL, present in both databases but with inconsistent values,
and present and identical in both databases. For continuous variables, e.g.
weight, we allowed differences within a narrow window, as noted in table
footnotes. Discrepancies between OPTN/SRTR and A2ALL data were inves-
tigated using paired t-tests, scatterplots and histograms of the differences
between the two values. For dichotomous variables, we tested whether
discrepancies were symmetric between OPTN/SRTR and A2ALL using Mc-
Nemar’s test. For variables with substantial missing data in OPTN/SRTR,
we compared the A2ALL data for those with missing values in OPTN/SRTR
to the complete data in OPTN/SRTR to see if the data were missing at ran-
dom (4). We used box plots to illustrate the distributions of center-specific
percent missing, tested for center differences in the proportion missing
using chi-square tests and graphically examined patterns of missing data
over calendar time.
A2ALL used the OPTN disease and cause of death codes, but allowed
more codes to be listed (3 instead of 2 diagnostic codes and 3 instead
of 1 cause of death codes). Of 66 unique diagnostic codes used, many
subjects had close but inexact matches in the two databases. We grouped
the codes into six diagnostic categories for matching: acute hepatic necro-
sis (AHN), noncholestatic cirrhosis (non-hepatitis C), hepatitis C, cholestatic
cirrhosis, metabolic disorders and hepatocellular carcinoma (HCC). The 55
unique cause of death codes reported were grouped into 14 categories:
liver disease, graft failure, cardiovascular, cerebrovascular, pulmonary insuf-
ficiency/respiratory failure, renal failure, multi-organ system failure, hemor-
rhage, infection, malignancy, operative, suicide, trauma and other. A match
was declared if a diagnostic or cause of death category was reported in
both OPTN and A2ALL.
Results
Data for 785 potential liver recipients, 594 transplant recipi-
ents and 386 living liver donors who had records in both the
A2ALL database and in OPTN/SRTR data were included.
Of the transplant recipients, 387 received an LDLT and 207
received a deceased donor liver transplant (DDLT).
Of 29 data elements for potential recipients most
concerned demographics or medical status at listing
(Table 1A).The majority were present and identical in
both OPTN/SRTR and A2ALL. Variables with greater than
90% identical values between OPTN/SRTR and A2ALL in-
cluded most demographics (gender, date of birth, ethnicity,
race), ABO blood type, weight, previous liver transplants,
medical condition and whether on a ventilator at listing,
some diagnoses, dialysis, reason for removal from the
waitlist and death date. Among variables with less than
90% matching between OPTN/SRTR and A2ALL, most
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nonmatches represented data present in A2ALL but miss-
ing in OPTN/SRTR, including education, height, diabetes,
coronary artery disease and hypertension. The collection of
some OPTN/SRTR data elements has changed over time.
For example, history of transjugular intrahepatic portosys-
temic shunt (TIPSS) has only been collected since 1999,
and serum creatinine at listing has been required since the
introduction of the MELD in 2002. No variable had more
than 3% missing in both SRTR and A2ALL except educa-
tion (8% missing) and INR (6% missing). Education was
poorly collected in both A2ALL and SRTR, with more than
25% missing in at least one. Overall, A2ALL centers sent
more complete data to A2ALL than they did to the OPTN.
Discrepancies of at least 10% were found for seven vari-
ables that had values recorded in both databases (diagnosis
at listing of noncholestatic cirrhosis, encephalopathy, as-
cites, previous upper abdominal surgery and post-MELD
creatinine, albumin and INR). Further analysis of the dis-
crepancies found potentially nonrandom differences (Ta-
ble 1B). For example, encephalopathy had unbalanced dis-
crepant values, with 3% ‘Yes’ for A2ALL and 10% ‘Yes’
for OPTN/SRTR (p = 0.0001). Both encephalopathy and
ascites were more likely to be recorded in OPTN/SRTR
than A2ALL before and after implementation of MELD-
based deceased donor liver allocation. For previous upper
abdominal surgery, the discrepant values were 11% ‘Yes’
for A2ALL and 5% ‘Yes’ for OPTN/SRTR (p < 0.0001). The
higher proportion reporting prior upper abdominal surgery
in A2ALL persisted despite thorough review of responses,
where many incorrect ‘Yes’ responses (e.g. appendectomy
and hysterectomy) were corrected to ‘No’. For date of birth,
only six cases differed (by 1 to 10 years), and no system-
atic bias by database was detected by paired t-test. For
height, 10 cases differed by at least 10 cm. For weight,
27 cases differed by at least 10 kg, with A2ALL reporting
significantly higher weights (p = 0.0001).
Of the variables in Table 1A with more than 10% of val-
ues missing in OPTN/SRTR but present in A2ALL, many
appeared to be missing completely at random, as indi-
cated by similar values in A2ALL among those missing in
OPTN/SRTR compared with those present in OPTN/SRTR.
Variables that did not appear to be missing completely at
random were angina/coronary artery disease (1% among
those present in OPTN/SRTR vs. 7% reported in A2ALL
among those missing in OPTN/SRTR, p = 0.0003), and ed-
ucation (higher attainment among those present vs. miss-
ing in OPTN/SRTR, p < 0.0001).
Of 17 transplant-related and two mortality variables, the
majority were present and identical in both OPTN/SRTR
and A2ALL (Table 2A). Data missing in both OPTN/SRTR
and A2ALL were uncommon, except for cold ischemia
time (CIT) among LDLT recipients (20%) and HCV RNA
result (32%). Among those with LDLT CIT recorded in
A2ALL, it was significantly shorter if CIT was missing in
OPTN/SRTR (mean 199 min) than if it was present (mean
334 min, p = 0.002). The same was true for the converse
combination (i.e. missing LDLT CIT in A2ALL and present
in OPTN/SRTR) for CIT recorded in OPTN/SRTR (256 vs.
339 min, p = 0.097). Variables with at least 10% missing
in OPTN/SRTR but present in A2ALL included: HCV RNA
(36% among 272 with HCV), cause of death (30% among
118 reported deaths), INR (28%), encephalopathy (28%)
and dialysis (29%) in the pre-MELD era, ALT (17%), treated
rejection during first year post-transplant (14%), and func-
tional status (11%). Variables present in OPTN/SRTR but
missing in A2ALL were less common, with the largest
percentages (approximately 6% in each case) for serum
albumin in the MELD era, LDLT CIT and HCV RNA. As with
pretransplant data, centers sent more complete recipient
data to A2ALL than they did to the OPTN.
Discrepancies of at least 10% were found for seven vari-
ables among non-missing recipient data: rejection treated
during the first year post-transplant (23% discrepant), en-
cephalopathy (pre-MELD, 13%; post-MELD, 17%), ascites
(post-MELD, 17%), functional status (14%), weight (11%),
albumin (post-MELD, 11%) and serum bilirubin (pre-MELD,
11%; post-MELD 12%) (Table 2A). Among cases with val-
ues present in both OPTN/SRTR and A2ALL there was
significant asymmetry for rejection treated during the first
year post-transplant, in that A2ALL more often showed
that rejection had occurred: 24% ‘Yes’ for A2ALL/‘No’ for
OPTN/SRTR and 3% ‘Yes’ for OPTN/SRTR/‘No’ for A2ALL
(p < 0.0001, Table 2B). A2ALL data also showed signif-
icantly more encephalopathy than OPTN/SRTR (16% vs.
2%; p < 0.0001) and TIPSS (4% vs. 1%; p = 0.0006).
OPTN/SRTR data recorded significantly more spontaneous
bacterial peritonitis than A2ALL (4% vs. 1%; p = 0.0002).
Although each continuous variable in Table 2B had a
few instances of extreme discrepancies, CIT exhibited a
systematic difference between OPTN/SRTR and A2ALL,
with shorter LDLT CIT values reported in A2ALL than
OPTN/SRTR (p = 0.0146) and longer DDLT CIT values re-
ported in A2ALL than OPTN/SRTR (p = 0.0014). There
were 16 LDLT CIT and 16 DDLT CIT values that were dis-
crepant by >1 hour. Although most albumin values were
identical in A2ALL and OPTN/SRTR, those that were differ-
ent were generally higher in A2ALL than in the OPTN/SRTR
data. Among the discrepant MELD components, 8 of 42
serum creatinine values differed by more than 1.0 mg/dL;
8 of 67 bilirubin values differed by more than 1.2 mg/dL;
and 12 of 46 INR values differed by more than 1.0. In
all cases, the distributions of differences were fairly sym-
metrical. For functional status, of the 80 with discrepant
values, 44 differed by a single level of the five New York
Heart Association classes.
Of the recipient transplant variables with more than 10%
of values missing in OPTN/SRTR but present in A2ALL,
all but rejection appeared to be missing at random,
as indicated by similar values in A2ALL among those
missing in OPTN/SRTR compared with those present in
1634 American Journal of Transplantation 2010; 10: 1630–1642




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1636 American Journal of Transplantation 2010; 10: 1630–1642

















































































































































































































































































































































































































































































































































































































































































































OPTN/SRTR. For rejection treated during the first year post-
tranplantation, 21% were reported as having rejection in
OPTN/SRTR versus 34% reported as having rejection in
A2ALL among those with missing values in OPTN/SRTR
(p = 0.009).
Among 12 living liver donor variables, most values were
present and identical in both databases (Table 3A). How-
ever, of the four donor deaths recorded in A2ALL data,
only two were recorded in OPTN/SRTR. Both were identi-
fied only by linkage to SSDMF and had not been entered to
OPTN by the center. Donor education was missing most
commonly (19% in both databases). Several variables had
substantial proportions of missing values in OPTN/SRTR
that were present in A2ALL: height (28%), weight (22%),
CMV IgG (24%) and education (20%). Variables where val-
ues were present in OPTN/SRTR but missing in A2ALL
were uncommon. Donor elements with values present
in both OPTN/SRTR and A2ALL but discrepant included
education (8%) and relationship to the recipient (6%)
(Table 3B). Donor variables with more than 10% missing
in OPTN/SRTR but present in A2ALL appeared to be miss-
ing at random, as indicated by similar values in A2ALL data
among those missing in OPTN/SRTR compared with those
present in OPTN/SRTR.
2009 national data from SRTR were analyzed to show the
distributions of percent missing across all U.S. liver trans-
plant programs for eight variables, separately for A2ALL
and non-A2ALL centers (Figure 1). These variables are
often tested in SRTR inferential models, and many have
been included in published SRTR-based research. There
was wide variation in the percent missing among programs
for each variable. Although well over one-half of programs
had 20% or less missing for all eight variables, a few had
30–95% missing values for several of the variables.
Discussion
This study provided a comprehensive comparison of OPTN
data with source data based on systematically collected
clinical information from nine major transplant centers. The
design of the A2ALL retrospective chart review provided
a unique opportunity to evaluate not only the accuracy of
nationally submitted transplant registry data, but the ex-
tent to which otherwise missing data may be captured
from a thorough review of the medical record by trained
personnel.
While the results demonstrated that most submitted
OPTN/SRTR data were consistent with A2ALL, substan-
tial problems with missing and discrepant data were re-
vealed. Missing OPTN/SRTR data were shown to exist by
their ability to be collected in A2ALL. The extent of avoid-
able missing OPTN/SRTR data was 10–12% for several
recipient candidate variables, up to 36% for transplant vari-
ables and up to 28% for donor variables. The pattern of
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Variable N N % N % N % N % N %
Demographics
Gender 386 1 0.3% 0 0.0% 0 0.0% 3 0.8% 382 99.0%
Ethnicity 386 1 0.3% 0 0.0% 1 0.3% 13 3.4% 371 96.1%









386 3 0.8% 6 1.6% 3 0.8% 14 3.6% 360 93.3%
Medical data
ABO blood type 386 1 0.3% 0 0.0% 1 0.3% 1 0.3% 383 99.2%
Height at
enrollment
386 7 1.8% 107 27.7% 0 0.0% 7 1.8% 265 68.7%
Weight2 386 1 0.3% 86 22.3% 1 0.3% 13 3.4% 285 73.8%
Relationship to
recipient
386 0 0.0% 1 0.3% 1 0.3% 22 5.7% 362 93.8%
CMV IgG at
enrollment
386 19 4.9% 93 24.1% 2 0.5% 13 3.4% 259 67.1%
Mortality follow-up3
Date of death 4 0 0.0% 2 50.0% 0 0.0% 0 0.0% 2 50.0%
Primary cause of
death
4 0 0.0% 4 100.0% 0 0.0% 0 0.0% 0 0.0%
1‘Same values’ were the values with difference between OPTN/SRTR and A2ALL ≤ 5 cm for height, 5 kg for weight.
2Donor weight at enrollment in A2ALLversus donor weight at transplant in OPTN/SRTR.
3Restricted to donors whose death was recorded in A2ALL.
less missing data at listing than at transplant or follow-up
may reflect a greater incentive for centers to enter com-
plete data prior to versus following the receipt of an organ
for transplant. An investigation of whether variables were
‘missing completely at random’ in the OPTN/SRTR data us-
ing the more complete data from A2ALL revealed several
variables that violated this assumption. In particular, the
presence of coronary artery disease and the occurrence
of treated rejection during the first year post-transplant
were both reported with significantly lower frequency in
OPTN/SRTR than in A2ALL. When educational attainment
was missing in OPTN/SRTR data, it was likely to be less
than average when found in A2ALL. Estimation of the as-
sociations of such variables with outcomes can be severely
biased if missing data are not missing at random.
Unresolved discrepancies between OPTN/SRTR and
A2ALL were common for some variables. Among con-
tinuous variables, CIT differed by hours in several cases.
For categorical variables, discrepancies of 9% to 28%
were found for previous upper abdominal surgery, pres-
ence of encephalopathy or presence of ascites at list-
ing. Some variables may be difficult to accurately code
based on medical chart review. However, variables such
as CIT and previous upper abdominal surgery have
been found to be significantly predictive of outcomes in
Table 3B: Comparison between OPTN/SRTR and A2ALL of selected data elements for donors among values present in both sources
Ordinal variables N Same value OPTN/SRTR higher A2ALL higher
Highest education level 228 198 (87%) 5 (2%) 25 (11%)
OPTN/SRTR: OPTN/SRTR: Both Both
biological, nonbiological, biological, nonbiological,
Same A2ALL: A2ALL: but different but different
Categorical variables N value nonbiological biological type type
Relationship to recipient 384 362 (94%) 6 (2%) 8 (2%) 6 (2%) 2 (0.5%)
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Figure 1: Boxplot distributions of per-
cent missing for OPTN/SRTR data
from all U.S. liver transplant cen-
ters for several recipient candidate
variables tested in SRTR analytic mod-
els (2009 data). (Func Status = func-
tional status by New York Heart Asso-
ciation scale; Vari Bld = variceal bleed;
Up Ab Surg = upper abdominal surgery;
HTN = hypertension.) Boxes show the
25th to 75th percentiles, ‘+’ = mean, and
bar across box = median. Whiskers ex-
tend to the data point closest to the cen-
ter within 1.5 ∗ IQR (interquartile range)
from each box end, and values beyond
these points are shown individually.
SRTR (5,6) and A2ALL (7), based on potentially flawed
data.
Because OPTN/SRTR data are used extensively for anal-
yses that inform medical practice and national transplant
policy, the consequences of these data issues must be
considered. For example, an analysis of treated rejection
during the first year after LDLT versus DDLT based on
OPTN/SRTR data (8) yielded conclusions that differed sub-
stantially from those based on a subsequent analysis of
A2ALL data (7,9). It is disconcerting that among A2ALL
subjects with rejection data, 23% had discrepant values
for rejection in OPTN/SRTR, and an additional 14% were
missing information on treated rejection in the OPTN/SRTR
data. These findings raise concerns about reports that rely
on OPTN/SRTR data on the incidence of acute rejection
(10), including publications funded by pharmaceutical cor-
porations that demonstrate putative benefits of particu-
lar products (11,12). A second programmatic implication
is the effect of missing or discrepant data on OPTN as-
sessment of program performance. Accurate estimation
of expected survival requires complex modeling based on
multiple donor and recipient variables. Unfortunately, large
amounts of missing data at individual centers degrade the
model estimates for all centers, with resultant biases of
unknown size and direction.
Missing values always have an impact on an analysis,
whether observations with missing data are deleted (lead-
ing to reduced statistical power and possible bias), in-
cluded with missing data indicators (leading to biased esti-
mates, possibly severe), or multiply imputed (the preferred
method, but still yielding reduced power compared with
complete data). Most SRTR publications have used the
second method, even with variables missing as much as
31% (education), 30% (variceal bleed) and 35% (functional
status) in models based on data from the most recent 3
years (5). This method can cause bias in parameter esti-
mates and standard errors of any variable in a regression
model (13,14), with higher proportions missing associated
with greater bias, although the impact on model prediction
is smaller.
We investigated center-level characteristics predictive of
missing data for two variables with substantial missing
data (CIT and education), with inconsistent results. For ex-
ample, higher center volume was significantly associated
with lower probability of missing CIT, but higher probabil-
ity of missing education. Significant but inconsistent dif-
ferences by calendar year were observed, and no signif-
icant geographic effects (rural, micro-urban, metro-urban)
were seen. The type of medical record system could con-
tribute to ease of data extraction, but was not known for
this analysis. The strongest predictive factor by far was
the effect of individual center, found in both models. Cen-
ter variability in percent missing was wide, with a minor-
ity of the centers accounting for the bulk of the miss-
ing data. For example, 65% of missing functional status
were from a handful of centers, each with 10–60% miss-
ing. Furthermore, centers with substantial missing data
on one variable were much more likely to have missing
data on other variables, with correlations between center
percent missing for pairs of variables ranging from 0.42
to 0.90.
1640 American Journal of Transplantation 2010; 10: 1630–1642
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A limitation of this study is that data were collected
mostly prior to 2004. However, many OPTN/SRTR anal-
yses still incorporate these data, and problems of miss-
ing data exist with more current (2009) OPTN/SRTR data
(Figure 1). Because of the thorough A2ALL chart reviews,
logic and error checks, further scrutiny during analyses for
A2ALL manuscripts (15–19), and the benefit of A2ALL
corrections after comparison with OPTN/SRTR data, we
believe most discrepancies represented errors or omis-
sions in submission of data to OPTN. Nevertheless, OPTN
data were submitted closer to the time of listing and
transplant and may have benefited from information avail-
able at those times that was not documented in the
patient charts. Another limitation is that the current re-
sults do not necessarily apply to other organ recipients or
donors.
Initiatives by OPTN to improve data quality have included
a decrease in the number of variables to reduce the bur-
den of data submission, building range and logic checks
into UNET and performance of periodic audits of cen-
ters to monitor accuracy of data submitted for alloca-
tion. The achievement of 100% complete data for vari-
ables required for liver organ allocation in the MELD era
is notable, and efforts have been made to report levels
of missing data. The annual SRTR Report on the State
of Transplantation has included papers on national trans-
plant data and analysis issues that examined how to over-
come the problem of missing outcomes using additional
sources of ascertainment, such as the SSDMF (20,21).
However, SRTR or the OPTN have not addressed miss-
ing or incorrect values for other variables. The use of
external databases, such as hospital databases, Medi-
care records (22,23) or private payer claims data (24) to
augment OPTN/SRTR data has been suggested. Given
that agreement between databases is far from perfect
(22–24), policies to deal with inconsistencies would have
to be developed. A future standardized national health
record could facilitate the electronic submission of hospi-
tal data, and would likely improve the quality of submitted
data.
Funding is often insufficient to have complete, correct and
timely data in large registry databases. Data collection
and monitoring in A2ALL required as much as one full-
time equivalent (FTE) coordinator per center and 2–3 FTEs
at the Data Coordinating Center. However, the quality of
OPTN/SRTR data might be improved by monitoring miss-
ing data frequencies for individual variables by center, in-
creasing the number of required variables, adding further
range or logic checks in UNET, and auditing sites for the
accuracy of variables other than those used for organ allo-
cation. Reporting of the number of subjects with missing
data should be standard in all peer-reviewed manuscripts
and in data reports from the OPTN and SRTR. Such actions
would improve the ability of the OPTN, SRTR and other in-
vestigators to address important scientific questions in the
field of solid organ transplantation.
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